World Health Organization Sounds Warning Over Acute Shortage of Obesity Medications

Less than one in 10 patients that would benefit from weight-loss injections like Wegovy are able to get them, caution the World Health Organization as it publishes its initial advice on the therapies.

With over a billion people worldwide currently living with obesity, it is advocating for broader and more equitable availability to these injectable treatments.

According to estimates, more than two billion are projected to be living with obesity by 2030 without intervention.

"Our latest guidance affirms that excess weight is a chronic disease that can be treated with holistic and ongoing treatment," stated its chief Tedros Adhanom Ghebreyesus.

Significant expense, insufficient output, and distribution challenges are key barriers to broad availability to the injections that can help people shift considerable body mass, says the body.

GLP-1 Therapy Scarcity

Despite the present most optimistic case, the manufacturing of such drugs might only reach approximately 100 million people – under 10% of the global need, as stated by the health organization.

The guideline calls on countries and companies to widen access, by strategies such as voluntary licensing.

The intellectual property rights on semaglutide – the core component of a leading brand – is scheduled to end in multiple nations in 2026.

How Obesity Drugs Work

GLP-1 drugs mimick a biological compound to delay gastric emptying, suppress the appetite and enhance the sense of being full so people eat less.

Individuals usually begin shedding pounds in the initial weeks of commencing the once-weekly jabs.

Research points to patients may put most of the weight back on a year later of discontinuing the medication, as their normal food cravings come back.

Being above a healthy weight increases your chance for contracting medical conditions, such as type 2 diabetes, cardiovascular issues, brain attack, and certain malignancies.

Obesity concerns individuals in every country and was associated with over three and a half million deaths worldwide in 2024, as per the health agency.